Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Marc Louis Copersino, Ph.D.

Concepts

This page shows the publications Marc Copersino has written about Humans.
Connection Strength

0.080
  1. Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry. Drug Alcohol Depend. 2020 01 01; 206:107728.
    View in: PubMed
    Score: 0.010
  2. Effects of cognitive impairment on substance abuse treatment attendance: predictive validation of a brief cognitive screening measure. Am J Drug Alcohol Abuse. 2012 May; 38(3):246-50.
    View in: PubMed
    Score: 0.006
  3. Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. Am J Drug Alcohol Abuse. 2010 Nov; 36(6):311-9.
    View in: PubMed
    Score: 0.005
  4. Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009 Oct; 17(5):337-44.
    View in: PubMed
    Score: 0.005
  5. Measurement of self-reported HIV risk behaviors in injection drug users: comparison of standard versus timeline follow-back administration procedures. J Subst Abuse Treat. 2010 Jan; 38(1):60-5.
    View in: PubMed
    Score: 0.005
  6. EEG and cerebral blood flow velocity abnormalities in chronic cocaine users. Clin EEG Neurosci. 2009 Jan; 40(1):39-42.
    View in: PubMed
    Score: 0.005
  7. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. Am J Addict. 2006 Jul-Aug; 15(4):297-302.
    View in: PubMed
    Score: 0.004
  8. Cannabis withdrawal among non-treatment-seeking adult cannabis users. Am J Addict. 2006 Jan-Feb; 15(1):8-14.
    View in: PubMed
    Score: 0.004
  9. Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Res. 2004 Oct 30; 128(3):209-18.
    View in: PubMed
    Score: 0.004
  10. Emergency psychiatry: rapid screening for cognitive impairment in the psychiatric emergency service: II. A flexible test strategy. Psychiatr Serv. 2003 Mar; 54(3):314-6.
    View in: PubMed
    Score: 0.003
  11. Clinical utility of the 15-item geriatric depression scale (GDS-15) for use with young and middle-aged adults. J Affect Disord. 2018 12 01; 241:59-62.
    View in: PubMed
    Score: 0.002
  12. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Exp Clin Psychopharmacol. 2014 Jun; 22(3):248-256.
    View in: PubMed
    Score: 0.002
  13. Motivations to quit cannabis use in an adult non-treatment sample: are they related to relapse? Addict Behav. 2013 Sep; 38(9):2422-7.
    View in: PubMed
    Score: 0.002
  14. Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend. 2012 Jun 01; 123(1-3):141-7.
    View in: PubMed
    Score: 0.001
  15. Brain mu-opioid receptor binding predicts treatment outcome in cocaine-abusing outpatients. Biol Psychiatry. 2010 Oct 15; 68(8):697-703.
    View in: PubMed
    Score: 0.001
  16. Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. Drug Alcohol Depend. 2010 Sep 01; 111(1-2):120-7.
    View in: PubMed
    Score: 0.001
  17. Conducting clinical research with prescription opioid dependence: defining the population. Am J Addict. 2010 Mar-Apr; 19(2):141-6.
    View in: PubMed
    Score: 0.001
  18. A method to diagnose opioid dependence resulting from heroin versus prescription opioids using the Composite International Diagnostic Interview. Contemp Clin Trials. 2010 Mar; 31(2):185-8.
    View in: PubMed
    Score: 0.001
  19. Reliability and validity of a short form of the Marijuana Craving Questionnaire. Drug Alcohol Depend. 2009 Jun 01; 102(1-3):35-40.
    View in: PubMed
    Score: 0.001
  20. Brain mu-opioid receptor binding: relationship to relapse to cocaine use after monitored abstinence. Psychopharmacology (Berl). 2008 Nov; 200(4):475-86.
    View in: PubMed
    Score: 0.001
  21. Longitudinal ECG changes in cocaine users during extended abstinence. Drug Alcohol Depend. 2008 May 01; 95(1-2):160-3.
    View in: PubMed
    Score: 0.001
  22. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharmacol. 2008 Jan 28; 579(1-3):160-6.
    View in: PubMed
    Score: 0.001
  23. Treatment programs in the National Drug Abuse Treatment Clinical Trials Network. Drug Alcohol Depend. 2008 Jan 01; 92(1-3):200-7.
    View in: PubMed
    Score: 0.001
  24. Direct care workers in the National Drug Abuse Treatment Clinical Trials Network: characteristics, opinions, and beliefs. Psychiatr Serv. 2007 Feb; 58(2):181-90.
    View in: PubMed
    Score: 0.001
  25. Effectiveness of motivational incentives in stimulant abusing outpatients with different treatment histories. Am J Drug Alcohol Abuse. 2007; 33(1):129-37.
    View in: PubMed
    Score: 0.001
  26. Risk of psychoactive substance dependence among substance users in a trauma inpatient population. J Addict Dis. 2007; 26(1):71-7.
    View in: PubMed
    Score: 0.001
  27. Sociodemographic characteristics associated with substance use status in a trauma inpatient population. J Addict Dis. 2007; 26(2):53-62.
    View in: PubMed
    Score: 0.001
  28. Attentional bias towards cocaine-related stimuli: relationship to treatment-seeking for cocaine dependence. Am J Drug Alcohol Abuse. 2007; 33(5):727-36.
    View in: PubMed
    Score: 0.001
  29. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study. Arch Gen Psychiatry. 2006 Feb; 63(2):201-8.
    View in: PubMed
    Score: 0.001
  30. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Arch Gen Psychiatry. 2005 Oct; 62(10):1148-56.
    View in: PubMed
    Score: 0.001
  31. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol Psychiatry. 2005 Jun 15; 57(12):1573-82.
    View in: PubMed
    Score: 0.001
  32. Opioid abuse and cognitive performance. Drug Alcohol Depend. 2005 May 09; 78(2):225-30.
    View in: PubMed
    Score: 0.001
  33. Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment. Am J Drug Alcohol Abuse. 2004 May; 30(2):237-49.
    View in: PubMed
    Score: 0.001
  34. Learning and memory impairment in cocaine-dependent and comorbid schizophrenic patients. Psychiatry Res. 2000 Feb 14; 93(1):21-32.
    View in: PubMed
    Score: 0.001
  35. Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients. J Subst Abuse. 2000; 11(2):205-13.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.